Page last updated: 2024-08-24

plerixafor and Colonic Neoplasms

plerixafor has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brancaccio, D; Carotenuto, A; D'Alterio, C; Di Leva, FS; Di Maro, S; Ieranò, C; La Pietra, V; Marinelli, L; Napolitano, M; Novellino, E; Portella, L; Scala, S; Sementa, D; Siciliano, RA; Tomassi, S; Trotta, AM	1

Other Studies

1 other study(ies) available for plerixafor and Colonic Neoplasms

Article	Year
Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists. Journal of medicinal chemistry, 2016, Sep-22, Volume: 59, Issue:18 Topics: Amino Acid Sequence; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Colonic Neoplasms; Humans; Leukemia; Models, Molecular; Peptides, Cyclic; Phosphorylation; Receptors, CXCR4	2016

Article

Year

Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists.

Journal of medicinal chemistry, 2016, Sep-22, Volume: 59, Issue:18

Topics: Amino Acid Sequence; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Colonic Neoplasms; Humans; Leukemia; Models, Molecular; Peptides, Cyclic; Phosphorylation; Receptors, CXCR4

2016